Work

113 Benefit-risk of ofatumumab in treatment-naïve early relapsing multiple sclerosis patients

Year: 2022

Type: article

Source: Journal of Neurology Neurosurgery & Psychiatry

DOI: 10.1136/jnnp-2022-abn.438

Authors: Jutta Gärtner, Stephen Hauser, Amit Bar-Or, Xavier Montalban, Jeffrey Cohen, Anne Cross, Kumaran Deiva, Dieter Häring, Wendy Su, et al

Institutions: Universitätsmedizin Göttingen, University of California, San Francisco, University of Pennsylvania, Vall d'Hebron Hospital Universitari, Cleveland Clinic, Bicêtre Hospital, Novartis (Switzerland), Novartis (United States)

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281741048

FWCI: 0.499

Cites:

Cited by: 5

Related to: 10